SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039490
Filing Date
2020-08-12
Accepted
2020-08-12 07:45:38
Documents
88
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-10q_20200630.htm 10-Q 2924282
2 EX-10.1 beam-ex101_197.htm EX-10.1 532233
3 EX-31.1 beam-ex311_9.htm EX-31.1 17836
4 EX-31.2 beam-ex312_8.htm EX-31.2 18220
5 EX-32.1 beam-ex321_7.htm EX-32.1 8529
6 EX-32.2 beam-ex322_6.htm EX-32.2 7943
7 GRAPHIC gwaattfdz5tx000001.jpg GRAPHIC 40810
  Complete submission text file 0001564590-20-039490.txt   10057502

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT beam-20200630.xml EX-101.INS 2109658
9 XBRL TAXONOMY EXTENSION SCHEMA beam-20200630.xsd EX-101.SCH 67385
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE beam-20200630_cal.xml EX-101.CAL 56985
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE beam-20200630_def.xml EX-101.DEF 225156
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20200630_lab.xml EX-101.LAB 449161
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20200630_pre.xml EX-101.PRE 388925
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 201094094
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences